陳冬平，廣州醫(yī)科大學(xué)附屬腫瘤醫(yī)院放療科，主任醫(yī)師（專業(yè)三級(jí)），碩士研究生、博士后導(dǎo)師

基本情況簡(jiǎn)介：

在廣州醫(yī)科大學(xué)附屬腫瘤醫(yī)院工作三十余年，擔(dān)任醫(yī)院黨委副書(shū)記、廣州市癌癥防治中心副主任、中國(guó)抗癌協(xié)會(huì)理事、中國(guó)抗癌協(xié)會(huì)鼻咽癌整合康復(fù)常務(wù)委員、廣東省抗癌協(xié)會(huì)理事、廣州市醫(yī)師協(xié)會(huì)副會(huì)長(zhǎng)、廣東省預(yù)防醫(yī)學(xué)會(huì)腫瘤防治委員會(huì)原主任委員、首屆廣州市優(yōu)秀健康科普專家，先后獲得2020年度“嶺南名醫(yī)”、第三屆“廣州醫(yī)師獎(jiǎng)”、“第五屆羊城好醫(yī)生”、“廣東醫(yī)院優(yōu)秀管理干部”、“廣州市優(yōu)秀管理干部”、“德醫(yī)雙馨‘2023人民好醫(yī)生’年度人物”、“2023年度廣州市衛(wèi)健委優(yōu)秀人才”等榮譽(yù)稱號(hào)。主持國(guó)家和省部級(jí)課題1項(xiàng)，參與多項(xiàng)國(guó)際、國(guó)內(nèi)多中心臨床研究，發(fā)表論文69篇，以第一作者或者通訊作者在Lancet oncol等發(fā)表SCI論文多篇，累計(jì)影響因子超200分，研究成果納入NCCN一線指南。

聯(lián)系方式:郵箱[email protected]；

研究領(lǐng)域

1、鼻咽癌微環(huán)境機(jī)制基礎(chǔ)和臨床相關(guān)研究

科研項(xiàng)目

1、國(guó)家自然科學(xué)基金面上項(xiàng)目，ZCRB1誘導(dǎo)鼻咽癌細(xì)胞代謝重編程促進(jìn)惡性表型和免疫耐受的作用及分子機(jī)制，2024年-2027年，49萬(wàn)

代表性論著（*第一作者，#通訊作者）

（1）Rui You, You-Ping Liu, Yu-Long Xie, Chao Lin, Chong-Yang Duan, Dong-Ping Chen, Yi Pan, Bin Qi, Xiong Zou, Ling Guo, Jing-Yu Cao, Yi-Nuan Zhang, Zhi-Qiang Wang, Yong-Long Liu, Yan-Feng Ouyang, Kai Wen, Qi Yang, Ruo-Qi Xie, Hui-Feng Li, Xiao-Tong Duan, Xi Ding, Lan Peng, Si-Yuan Chen, Jiong-Lin Liang, Zheng-Kai Feng, Tian-Liang Xia, Rui-Ling Xie, Rou Jiang, Chen-Mei Gu, Rong-Zeng Liu, Rui Sun, Xin Yang, Li-Zhi Liu, Li Ling, Qing Liu, Wai Tong Ng, Yi-Jun Hua, Pei-Yu Huang, Ming-Yuan Chen, Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomized, open-label, phase 3 trial. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. PMID: 36842439.（共一）

（2）Pan D, Rong X, Chen D, Jiang J, Ng WT, Mai H, Li Y, Li H, Cai J, Cheng J, Xu Y, Chua MLK, Simone CB 2nd, Lattanzi S, Tang Y. Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: A multicentre, retrospective, registry-based cohort study. EClinicalMedicine. 2022 Aug 12;52:101618. doi: 10.1016/j.eclinm.2022.101618. PMID: 36034411; PMCID: PMC9399256.（共一）

（3）Zhang, Xue-Fang#, Zhang, Yan#, Lian, Xu-Wei, Chen, Jia-Luo, Zhi, Sheng-Fang, Yin, Wen-Jing, Wang, Meng-Yao, Dong, En-Lai, Chen, Dong-Ping*. Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis. Front Oncol. 2021 Oct 1;11:726179. doi: 10.3389/fonc.2021.726179. PMID: 34660291; PMCID: PMC8517449.（通訊作者）

（4）Yin, Wen-Jing#, Chen, Dong-Ping#, Wang, Meng-Yao, Zheng, Lu, Dong, En-Lai, Liu, Jin-Quan, Qi, Bin*.Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Ann Transl Med. 2021 Aug;9(16):1313. doi: 10.21037/atm-21-3130. PMID: 34532450; PMCID: PMC8422106.（共一）

（5）Wang, Meng-Yao#, Qi, Bin#, Wang, Fang#, Lin, Zhi-Rui, Li, Ming-Yi, Yin, Wen-Jing, Zhu, Yan-Yi, He, Lu, Yu, Yi, Yang, Fang, Liu, Jin-Quan*, Chen, Dong-Ping*. PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma. Oncogenesis. 2021 Apr 30;10(4):35. doi: 10.1038/s41389-021-00325-y. Erratum for: Oncogenesis. 2021 Jan 5;10(1):9. PMID: 33931605; PMCID: PMC8087672.（共同通訊）

（6）Tang, Lin-Quan#, Chen, Dong-Ping#, Guo, Ling#, Mo, Hao-Yuan#, Huang, Ying#, Guo, Shan-Shan#, Qi, Bin, Tang, Qing-Nan, Wang, Pan, Li, Xiao-Yun, Li, Ji-Bin, Liu, Qing, Gao, Yuan-Hong, Xie, Fang-Yun, Liu, Li-Ting, Li, Yang, Liu, Sai-Lan, Xie, Hao-Jun, Liang, Yu-Jing, Sun, Xue-Song, Yan, Jin-Jie, Wu, Yi-Shan, Luo, Dong-Hua, Huang, Pei-Yu, Xiang, Yan-Qun, Sun, Rui, Chen, Ming-Yuan, Lv, Xing, Wang, Lin, Xia, Wei-Xiong, Zhao, Chong, Cao, Ka-Jia, Qian, Chao-Nan, Guo, Xiang, Hong, Ming-Huang, Nie, Zhi-Qiang, Chen, Qiu-Yan, Mai*, Hai-Qiang. Mai*. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial[J].Lancet Oncol,2018, 19(4): 461-473.（共一）